Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Gastroenterology & Hepatology
|
October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose, Laura Napoleone, Ahmed Amin, et al.
The Lancet Regional Health. Europe
|
June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease
Nicola Pugliese, Trenton M White, Paul N Brennan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Hepatology Communications
|
December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Elisa Pose, Elsa Solà, Juan J Lozano, et al.
Hepatology (Baltimore, Md.)
|
April 5, 2020
Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis
Tejasav S Sehrawat, Juan P Arab, Mengfei Liu, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Journal of Hepatology
|
October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Thomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Journal of Hepatology
|
November 28, 2024
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2024
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage
Irene González-Recio, Naroa Goikoetxea-Usandizaga, Claudia M Rejano-Gordillo, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Gastroenterology & Hepatology
|
October 15, 2019
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial
Elisa Pose, Laura Napoleone, Ahmed Amin, et al.
The Lancet Regional Health. Europe
|
June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease
Nicola Pugliese, Trenton M White, Paul N Brennan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Hepatology Communications
|
December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
Elisa Pose, Elsa Solà, Juan J Lozano, et al.
Hepatology (Baltimore, Md.)
|
April 5, 2020
Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis
Tejasav S Sehrawat, Juan P Arab, Mengfei Liu, et al.
Nature Reviews. Gastroenterology & Hepatology
|
September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease
Luis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.
Journal of Hepatology
|
October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Thomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Journal of Hepatology
|
November 28, 2024
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2024
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage
Irene González-Recio, Naroa Goikoetxea-Usandizaga, Claudia M Rejano-Gordillo, et al.
Page
of 10